Literature DB >> 1304452

Heart in adrenal diseases.

T Janota1, J Hradec, J Král.   

Abstract

The paper reviews the hitherto rather scarce literature concerned with cardiac changes in phaeochromocytoma, primary hyperaldosteronism and Cushing syndrome, and presents the authors' own echocardiographic findings in these diseases. In phaeochromocytoma they found a slight thickening of the interventricular septum which, however, did not fulfil the criteria of asymmetric left ventricular hypertrophy. Also other parameters showed higher values attesting to an increased left ventricular mass, however, without exceeding normal limits. Focal disturbances of left ventricular kinetics and the decrease in LV systolic function were non significant. The picture of obstructive hypertrophic cardiomyopathy, frequently mentioned in the literature, was observed only once, giving grounds to the suspicion that it is only a nonspecific manifestation of the hypercontractile state of the myocardium. In primary hyperaldosteronism only slight posterior LV wall thickening and an increase in the LV mass index were found, compared to control group. No significant changes were found in Cushing syndrome besides a tendency to concentric LV hypertrophy. Echocardiographic changes observed in all three affections disappeared after successful surgical or drug treatment.

Entities:  

Mesh:

Year:  1992        PMID: 1304452

Source DB:  PubMed          Journal:  Cor Vasa        ISSN: 0010-8650


  3 in total

1.  An unusual case of cardiomyopathy in a 75-year-old woman.

Authors:  J G J Milhous; A Mosterd; W Jaarsma; S M Roeffel
Journal:  Neth Heart J       Date:  2005-02       Impact factor: 2.380

Review 2.  Left heart morphology and function in primary aldosteronism.

Authors:  Alberto Milan; Corrado Magnino; Ambra Fabbri; Michela Chiarlo; Giulia Bruno; Isabel Losano; Franco Veglio
Journal:  High Blood Press Cardiovasc Prev       Date:  2012-03-01

3.  Cushing's syndrome patient who exhibited congestive heart failure.

Authors:  L Petramala; P Battisti; G Lauri; L Palleschi; D Cotesta; M Iorio; G De Toma; S Sciomer; C Letizia
Journal:  J Endocrinol Invest       Date:  2007-06       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.